Financial Performance

As autonomous AI agents begin managing trillions in commerce, a new identity crisis is brewing. We explore the critical need for governance and the tech aiming to solve it.

Fintech firm Hometap is betting its new pricing can make home equity investments a true rival to HELOCs, ditching monthly payments for a share of future value.

Novara's Form Agent automates EHS paperwork, signaling a larger strategic shift towards AI-driven operational risk management across the industry.

A look at how a Massachusetts ABA provider turns clinical assessments into a viable business blueprint, using expert insights and innovative media to scale trust.

California homeowners face a new hurdle: insurers are requiring automatic water shut-off devices to combat costly leaks, reshaping risk in a post-wildfire era.

A $25M deal is funding a luxury manufacturer's expansion, revealing a larger story about shifting supply chains and the global appetite for affordable luxury.

A new wave of investment aims to shield America's industrial backbone from cyber threats, bringing modern software discipline to the factory floor.

Quoin Pharma's new data for a rare skin disease shows life-changing results in children, offering hope for families. What do the numbers really mean?

With patient dosing underway for its fibroblast-based DFU therapy, FibroBiologics is testing a new paradigm: healing chronic wounds from within.

With its new stablecoin reserve fund, State Street isn't just launching a product. It's forging a regulated path where traditional finance and digital currency finally meet.

In a strategic pivot, GeneDx brings in former Quest and Thermo Fisher exec Mark Gardner to translate its genomic leadership into commercial dominance.

Eli Lilly's strategic buyout of a Texas biotech isn't just a deal; it's a bet on a new scientific paradigm to solve the chronic pain crisis without opioids.

A new partnership highlights how regulatory pressure and data analytics are forcing skilled nursing facilities to adopt tech for safer, more efficient patient care.

Amid soaring costs and licensing chaos from market incumbents, Opti9's exclusive deal to distribute Virtuozzo offers a critical lifeline to North American firms.

A small tech firm's entry into the Russell Microcap Index is more than a milestone; it’s a test case for the financial world's appetite for decentralized AI.

Millions of adults are straightening their teeth, but not with braces. We examine the tech, economics, and human behavior driving the clear aligner boom.

While other markets follow seasonal whims, Virginia Beach real estate operates on a different clock—one set by military transfer orders and a robust local economy.

The acquisition of E4E Solutions signals a major shift, creating an end-to-end powerhouse aimed at closing the gap between energy strategy and execution.

A new project management tool offers unlimited users for just $15.99/month, challenging giants like Asana. But can this radical model actually work?

With veteran investor Travis Read as new President & COO, AmMax Bio signals a major push to accelerate its promising antibody-drug conjugate pipeline.